Genentech

SUSVIMO

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / SUSVIMO – J2779

Manufacturer:

Genentech

Name:

SUSVIMO

HCPCS Code Descriptor:

Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg

Category:

J Code

HCPCS:

J2779

NDC(s):

50242-0078-55, 50242-0078-12

Primary Type:

Opthalmic

Generic Status:

Single-Source

Route of Administration:

Intraocular

About:

SUSVIMO is an Opthalmic drug manufactured by Genentech and administered via the Intraocular route of administration. The J Code: J2779 is aligned to the drug SUSVIMO.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/22

HCPCS Effective Date:

7/1/22

HCPCS Short Description:

Inj, susvimo 0.1 mg

Billing and Coding Guide:

https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/SUSVIMO-Billing-Coding-for-wet-AMD.pdf

Patient Assistance:

https://www.gene.com/patients/patient-foundation